Benefit Broker Resolution: Avoid Burnout

Benefit Broker Resolution: Avoid Burnout

Like the rest of American workers, pharmacy benefit brokers are burning out. Rising healthcare and drug costs, ever-changing policies, and transparency wars are adding to the complexity of benefit plan management. Fortunately, tools are available that automate...
Save by Switching from High-Cost Generics

Save by Switching from High-Cost Generics

Switching from an expensive brand-name medication to a lower-cost generic alternative is a proven savings strategy self-insured plan sponsors employ to reduce plan and participant costs. However, plans may miss significant savings by focusing only on brand-to-generic...
Drug Pricing and the Inflation Reduction Act

Drug Pricing and the Inflation Reduction Act

The passage of the Inflation Reduction Act (IRA) in August 2022 will impact patients, providers, and benefit plan sponsors by disrupting drug pricing. The IRA allows the Department of Health and Human Services to negotiate specific drug prices for the Medicare...
Interchangeable Biosimilars: Plan and Patient Savings

Interchangeable Biosimilars: Plan and Patient Savings

Biosimilar drugs are “highly similar to” and have “no clinically meaningful differences” from existing FDA-approved biologics. Currently, there are 38 biosimilars on the market, giving patients safe, cost-effective alternatives to high-cost biologics. Adoption of...
Medical Pharmacy Affects Plan Spend

Medical Pharmacy Affects Plan Spend

Pharmacy costs get all the press for rising prices; however, brokers and plan sponsors need to consider medical pharmacy if they want a complete picture of plan spend. Medical pharmacy is the management of drugs billed under the medical benefit. Most often, these...